Back
EHRA Premium Access

Paced P-wave duration as a significant predictor for atrial high-rate episodes in patients with cardiac implantable electronic devices

Session: Moderated ePosters - News on pacing
Topic: Antibradycardia Pacing
Speaker: Doctor J. Rubio Campal (Madrid, ES)
Event: EHRA 2022

Presentation

0

About the speaker

Doctor Jose Manuel Rubio Campal

Foundation Jimenez Diaz, Madrid (Spain)
0 follower

7 more presentations in this session

In silico study of anti-tachycardia pacing efficacy optimisation through scar-targeted stimulation

Speaker: Doctor S. Qian (London, GB)

Access
Abstract
Slides
0
Thumbnail

Early experience with the second generation of leadless pacemakers and correlation with ecg parameters

Speaker: Doctor A. Breitenstein (Zurich, CH)

Access
Abstract
Slides
0
Thumbnail

VDD leadless pacemaker: atrioventricular synchrony predictors

Speaker: Doctor A. Estevez Paniagua (Madrid, ES)

Access
Abstract
Slides
0
Thumbnail

Left bundle branch area pacing: feasible, safe and successful

Speaker: Doctor A. Estevez Paniagua (Madrid, ES)

Access
Abstract
Slides
1
Thumbnail

Left bundle branch pacing preserves ventricular mechanical synchrony better than right ventricular pacing-a two-center study

Speaker: Doctor Y. Mao (Hangzhou, CN)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Moderated ePosters - News on pacing

Speakers: Doctor J. Rubio Campal, Doctor S. Qian, Doctor A. Breitenstein, Doctor A. Estevez Paniagua, Doctor A. Estevez Paniagua...
Access
0
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

Related content

EHRA Premium Access

Atrial high-rate episodes in patients with devices without a history of atrial fibrillation

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

Biventricular versus conduction system pacing after atrioventricular node ablation in heart failure patients with atrial fibrillation

3 April 2022

This platform is supported by

logo Novo Nordisk